Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-18-002975
Filing Date
2018-03-14
Accepted
2018-03-14 17:07:40
Documents
10

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2250505
2 GRAPHIC g480882g20i92.jpg GRAPHIC 98716
3 GRAPHIC g480882g32e42.jpg GRAPHIC 46442
4 GRAPHIC g480882g44w52.jpg GRAPHIC 85948
5 GRAPHIC g480882g56n52.jpg GRAPHIC 80766
6 GRAPHIC g480882g60z88.jpg GRAPHIC 106882
7 GRAPHIC g480882g65b18.jpg GRAPHIC 54310
8 g480882g82j86.jpg GRAPHIC 98911
9 GRAPHIC g480882g91k30.jpg GRAPHIC 119402
10 GRAPHIC g480882g96m80.jpg GRAPHIC 102150
  Complete submission text file 0000950123-18-002975.txt   3335745
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01813 | Film No.: 18690199
SIC: 2834 Pharmaceutical Preparations